Cargando…
Digital technologies: Innovations that transform the face of drug development
Recently, digital health technologies (DHTs) and digital biomarkers have gained a lot of traction in clinical investigations, motivating sponsors, investigators, and regulators to discuss and implement integrated approaches for deploying DHTs. These new tools present new and unique challenges for op...
Autores principales: | Izmailova, Elena S., AbuAsal, Bilal, Hassan, Hazem E., Saha, Anindita, Stephenson, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432869/ https://www.ncbi.nlm.nih.gov/pubmed/37157935 http://dx.doi.org/10.1111/cts.13533 |
Ejemplares similares
-
Empowering drug development: Leveraging insights from imaging technologies to enable the advancement of digital health technologies
por: Izmailova, Elena S., et al.
Publicado: (2022) -
Digital health technology derived measures: Biomarkers or clinical outcome assessments?
por: Izmailova, Elena S., et al.
Publicado: (2023) -
Digital biomarkers: Convergence of digital health technologies and biomarkers
por: Vasudevan, Srikanth, et al.
Publicado: (2022) -
Digital transformation of business model innovation
por: Tsai, Wan-Yi, et al.
Publicado: (2022) -
Digital business transformation in innovation and entrepreneurship
por: Sedera, Darshana, et al.
Publicado: (2022)